The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
News|Articles|December 31, 2006
How to “Nail” the Size of Skin Lesions
Knowing the width of one of yourfingernails (mine is 15 mm) can helpyou quickly assess the size of skinlesions.
Advertisement
Knowing the width of one of yourfingernails (mine is 15 mm) can helpyou quickly assess the size of skinlesions.---- Kurt D. Fullmer, PA-C
Spokane, Wash
Advertisement
Related to this article
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
3
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
4
ACCORD Trials: Efficacy and Safety of Dextromethorphan-Bupropion in Agitation
5